Santarus, Inc.
🏢 View company profile →7Patents
6Active
7Granted
42Portfolio score
Filing activity: May 25, 2005 → Aug 31, 2018 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8993599B2 | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them | Human Necessities | 7 | Active |
| US10316095B2 | Antibody formulations | Chemistry; Metallurgy | 6 | Active |
| US10071058B2 | Controlled-release solid dosage forms of mesalamine | Human Necessities | 1 | Active |
| US10555907B2 | Controlled-release solid dosage forms of mesalamine | Human Necessities | 0 | Active |
| US10160808B2 | Anti-VLA1 (CD49A) antibody pharmaceutical compositions | Chemistry; Metallurgy | 0 | Active |
| US8906940B2 | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them | Human Necessities | 0 | Expired |
| US8815916B2 | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.